Saudi Arabia Biopharmaceuticals Contract Manufacturing Market Size & Outlook

The biopharmaceuticals contract manufacturing market in Saudi Arabia is expected to reach a projected revenue of US$ 341.0 million by 2030. A compound annual growth rate of 11.7% is expected of Saudi Arabia biopharmaceuticals contract manufacturing market from 2025 to 2030.
Revenue, 2024 (US$M)
$175.1
Forecast, 2030 (US$M)
$341.0
CAGR, 2025 - 2030
11.7%
Report Coverage
Saudi Arabia

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Saudi Arabia biopharmaceuticals contract manufacturing market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Saudi Arabia biopharmaceuticals contract manufacturing market highlights

  • The Saudi Arabia biopharmaceuticals contract manufacturing market generated a revenue of USD 175.1 million in 2024 and is expected to reach USD 341.0 million by 2030.
  • The Saudi Arabia market is expected to grow at a CAGR of 11.8% from 2025 to 2030.
  • In terms of segment, mammalian was the largest revenue generating source in 2024.
  • Non-mammalian is the most lucrative source segment registering the fastest growth during the forecast period.


Biopharmaceuticals contract manufacturing market data book summary

Market revenue in 2024USD 175.1 million
Market revenue in 2030USD 341.0 million
Growth rate11.8% (CAGR from 2024 to 2030)
Largest segmentMammalian
Fastest growing segmentNon-mammalian
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationMammalian, Non-mammalian
Key market players worldwideBoehringer Ingelheim, Lonza Group Ltd, Innovent Biologics Inc, Rentschler Biopharma SE, JRS Pharma, AGC Inc, AGC Biologics, Probiogen, FUJIFILM Holdings Corp, Toyobo Co Ltd, Samsung Electronics Co Ltd, Thermo Fisher Scientific Inc, WuXi Biologics (Cayman) Inc, AbbVie Inc, Novartis AG ADR, Catalent Inc, ADMA Biologics Inc, Pfizer Inc, Siegfried Holding AG, Cambrex, Binex


Other key industry trends

  • In terms of revenue, Saudi Arabia accounted for 0.4% of the global biopharmaceuticals contract manufacturing market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, South Africa biopharmaceuticals contract manufacturing market is projected to lead the regional market in terms of revenue in 2030.
  • UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 174.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biopharmaceuticals Contract Manufacturing Market Companies

Name Profile # Employees HQ Website
Binex View profile 101-250 Torrance, California, United States, North America https://www.binexline.com
Cambrex View profile 1001-5000 East Rutherford, New Jersey, United States, North America http://www.cambrex.com
ADMA Biologics Inc View profile 624 465 State Route 17, Ramsey, NJ, United States, 07446 https://www.admabiologics.com
Probiogen View profile 251-500 Berlin, Berlin, Germany, Europe http://www.probiogen.de
AGC Biologics View profile 1001-5000 Bothell, Washington, United States, North America http://www.agcbio.com/
JRS Pharma View profile 11-50 Rosenberg, Baden-Wurttemberg, Germany, Europe http://jrspharma.com
Innovent Biologics Inc View profile 4872 168 Dongping Street, Suzhou Industrial Park, Jiangsu, Suzhou, China, People's Republic of, 215123 https://www.innoventbio.com
Rentschler Biopharma SE View profile 501-1000 Laupheim, Baden-Wurttemberg, Germany, Europe https://www.rentschler-biopharma.com
Siegfried Holding AG View profile 4180 Untere Bruehlstrasse 4, Zofingen, Switzerland, CH-4800 https://www.siegfried.ch
Catalent Inc View profile 17219 14 Schoolhouse Road, Somerset, NJ, United States, 08873 https://www.catalent.com
WuXi Biologics (Cayman) Inc View profile 12740 No. 108, Meiliang Road, Mashan Binhu District, Wuxi, China, People's Republic of, 214092 https://www.wuxibiologics.com
AGC Inc View profile 61671 1-5-1, Marunouchi, Chiyoda-ku, Tokyo, Japan, 100-8405 https://www.agc.com
Toyobo Co Ltd View profile 12460 2-8, Dojima Hama 2-chome, Kita-ku, Osaka, Japan, 530-8230 http://www.toyobo.co.jp
Boehringer Ingelheim View profile 10001+ Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe https://www.boehringer-ingelheim.com/
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Samsung Electronics Co Ltd View profile 124804 129, Samsung-ro, Yeongtong-gu, Gyeonggi-do, Suwon-si, Korea, Republic of, 443-742 https://www.samsung.com
FUJIFILM Holdings Corp View profile 83784 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 http://www.fujifilmholdings.com
Lonza Group Ltd View profile 18000 Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 https://www.lonza.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
AbbVie Inc View profile 50000 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 http://www.abbvieinvestor.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com

Saudi Arabia biopharmaceuticals contract manufacturing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceuticals contract manufacturing market will help companies and investors design strategic landscapes.


Mammalian was the largest segment with a revenue share of 56.6% in 2024. Horizon Databook has segmented the Saudi Arabia biopharmaceuticals contract manufacturing market based on mammalian, non-mammalian covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Saudi Arabia biopharmaceuticals contract manufacturing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Saudi Arabia biopharmaceuticals contract manufacturing market databook

  • Our clientele includes a mix of biopharmaceuticals contract manufacturing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia biopharmaceuticals contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia biopharmaceuticals contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Saudi Arabia biopharmaceuticals contract manufacturing market size, by source, 2018-2030 (US$M)

Saudi Arabia Biopharmaceuticals Contract Manufacturing Market Outlook Share, 2024 & 2030 (US$M)

Saudi Arabia biopharmaceuticals contract manufacturing market size, by source, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online